Vol 27, No 6 (2022)
Research paper
Published online: 2022-11-02

open access

Page views 3408
Article views/downloads 359
Get Citation

Connect on Social Media

Connect on Social Media

research paper

Reports of Practical Oncology and Radiotherapy

2022, Volume 27, Number 6, pages: 1019–1025

DOI: 10.5603/RPOR.a2022.0114

Submitted: 06.10.2022

Accepted: 27.10.2022

© 2022 Greater Poland Cancer Centre.

Published by Via Medica.

All rights reserved.

e-ISSN 2083–4640

ISSN 1507–1367

Physical parameters in thermal imaging of basal cell cancer patients treated with high-dose-rate brachytherapy first study

Łukasz Kapek12Agnieszka Cholewka3Agnieszka Szurko1Agata Stanek4Marta Szlag3Krzysztof Ślosarek3Piotr Wojcieszek5Armand Cholewka1
1Faculty of Science and Technology, University of Silesia, Chorzów, Poland
2Department of Medical Physics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
3Radiotherapy Planning Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
4Department and Clinic of Internal Diseases, Angiology and Physical Medicine, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Bytom, Poland
5Brachytherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland

Address for correspondence: Łukasz Kapek, Faculty of Science and Technology, University of Silesia, 75 Pułku Piechoty 1A, 41–500 Chorzów, Poland; e-mail: lukaszkapek@gmail.com

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially

Abstract
Background: The basal cell carcinoma (BCC) is often treated by surgery or radiotherapy using ionizing radiation. While there is an established diagnostic path before treatment and also for the follow-up there are no good noninvasive methods objectifying irradiated area evolution during treatment. The main goal of preliminary studies was to try to answer if there are any useful information that can be derived from temperature effects of high-dose-rate (HDR) brachytherapy in treatment of BCC. Moreover, the temperature gradient was introduced as a physical parameter characterizing the thermal map of the lesion, its surroundings and reference area, which provided information about cancer tissue thermal reaction to brachytherapy.
Materials and methods: Thirty-three patients suffering from BCC were monitored with thermovision during the brachytherapy treatment. All lesions were diagnosed as superficial and were confirmed with histopathology examination.
Results: Results of the study showed two groups of patients characterized with two thermal maps and temperature gradient describing the lesion and surrounding area of BCC. The first group was characterized by higher temperature of the lesion than the surrounding tissue temperature (mean dT = 0,41°) whereas the other one, with lower lesion temperature (mean dT = –0.42°). It seems that the temperature changes observed in designated areas before and after therapy may provide physicians with additional information which could be useful in planning the treatment process, especially when considering temperature gradient changes during therapy.
Conclusions: Although the data obtained indicate the possibilities of temperature distribution in pre-irradiation cases, further research is required for estimation of clinical effects of treatment.
Key words: thermal imaging; basal cell carcinoma; thermovision diagnostics
Rep Pract Oncol Radiother 2022;27(6):1019–1025

Introduction

Non-melanoma skin cancers are the most common malignant neoplasms in Caucasians [1, 2]. This type of lesions rarely leads to metastases and patient death [3–7]. The exception are people undergoing chronic immunosuppression or with genetic predisposition to develop skin cancer induced by ultraviolet radiation. Probability of aesthetic defects, such as infiltration and destruction of adjacent tissues, is also a significant clinical problem. Such occurrences can significantly reduce the quality and comfort of patient’s life. Basal cell carcinoma (BCC) is the most common skin cancer, accounting for approximately 80% of all non-melanoma skin cancers [3, 4, 8]. It arises from the cells of the basal layer of the epidermis and is characterized by slow growth and local malignancy. Most often, BCCs are located in the head and neck area [7–10]. In 90% of cases, cancer occurs between the hairline and the upper lip [11]. It can also affect the arms, back, and back of the hands. It shows an increasing tendency with the age of patients, and most disease cases are observed in the eighth decade of life, but they are also reported in younger patients, even adolescents [5].

There are various guidelines available that describe diagnostic evaluation, treatment possibilities and follow-up [12, 13]. Surgery, particularly Mohs surgery, remains the standard of care for skin cancer patients; however, interest in radiation therapy increases. One of the irradiation techniques used in the treatment of basal cell carcinoma is high-dose-rate brachytherapy (HDR BT). It is effective in either primary, adjuvant or recurrence treatment. It is an alternative for patients who cannot undergo surgery due to comorbidities, age or lack of consent [12, 14]. Brachytherapy provides a radiation dose precisely due to the positioning of the radioactive isotope inside (interstitial brachytherapy) or near the tumour (surface brachytherapy) [14, 15]. High conformity of this method allows better protection of healthy tissues surrounding the tumor. However, acute and late complications are observed, including itching, redness, peeling, ulceration, bleeding, telangiectasia or fistula.

Tumour growth is affected by cells’ division and microenvironmental changes, mainly growing vasculature; hence local metabolism rises [16]. Such processes increase the temperature in soft tissue and may reflect on the skin surface as a specific thermal map. That is why thermovision may be helpful in imaging skin lesions as a quick and non-invasive tool for examination. As many publications show, thermal imaging may indicate potentially cancerous areas characterized by different average temperatures compared to healthy skin temperatures. Thermal imaging seems to be a good technique to evaluate the energy administered to the tissue due to radiation therapy due to increased energy production in the affected and then irradiated area and, consequently, increased body temperature [10, 17–22]. However, at present, thermovision cannot be used as the sole diagnostic method. Therefore, research is needed to confirm the usefulness of using thermal imaging.

Materials and methods

The Bioethics Committee approved the study at the Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw. All patients gave their informed written consent. The study was carried out by the Faculty of Science and Technology, University of Silesia, Chorzów, in cooperation with the Department of Brachytherapy, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch.

Patients

The analyzed group included 33 patients (17 female and 16 male) with histopathologically confirmed BCC in the head area. Every patient was treated using a custom-made mould applicator based on the individual anatomic features. A three-dimensional HDR-BT CT-based treatment plan was prepared. A total dose of 45 Gy in 9 fractions was prescribed 5 mm from the applicator surface; however, dose optimization was used depending on anatomy or organs at risk, e.g., eyeball, bones, a curvature of the area. Fractions were delivered twice a week. During the treatment and one month afterwards, each patient was requested to avoid physical exercise, stimulants, smoking, alcohol or hot drinks for at least 3 hours before thermal imaging diagnosis [22].

Methodology

Before thermovision, the examined patient should rest a minimum of 15 minutes under controlled conditions. Any physical activity may increase blood flow and metabolism’s processes affecting the thermovision. The examined areas should not be covered with clothes or bandage while waiting for the exam to get accustomed to the surrounding temperature [23].

The thermal imaging examination was carried out twice: up to two weeks before treatment start and a month after the delivery of the last treatment fraction.

It should be noted that the researchers tried to avoid of different undesirable skin reactions. That is why directly or several days after treatment, due to exudate, radiation reaction, ulceration, or other effects of BT, it was difficult to clearly define the area that should be subjected to thermal imaging measurements. Therefore, we focused on the temperature effects occurring in the treated tissues before and one month after the brachytherapy.

Every time thermal and digital photos of the treated area with its surrounding healthy tissue and the reference area were taken. Reference area was defined as the symmetric area to the neoplastic lesion, with the axis of symmetry defined as the sagittal axis of human body. A similar methodology was used by Flores Sahagun et al. [24]. According to the protocol, the irradiated area was marked as the T area, the area approximately 2cm around (depending on the place of lesion) the T area as the S area. The reference area was marked as the R area.

Each thermal image was correlated with a digital photo of the examined area. The T and the R areas were identified in the thermal image and outlined with the help of a physician.

The tests were carried out using a Flir Systems E60 thermal imaging camera with the following parameters: sensitivity < 0.05°C, refreshing sensitivity 60 Hz, detector resolution 320 × 240 pixels. Measurements were made in a room with a stable temperature (23.0 ± 1°C) and a humidity of 50%. Moreover, thermal camera was set perpendicular to the body surface and the distance between the camera and body was fixed at 0.5 meter according to the standards of thermal imaging diagnostics in medicine [22, 24].

Data analysis

ThermaCAMResearcher Professional 2.10 program was used to analyze the thermograms. The obtained thermal images were presented using the Medical scale.

Statistical analysis was performed in Microsoft Office Excel 2013 and Statistica.

During data analysis corresponding differences has been calculated:

dTTS = TTarget – TSurroundings (1)

dTTR = TTarget – TRefference (2)

dTSR = TSurroundings – TRefference (3)

Results

Figure 1 presents the patient’s thermal images with delineated analysed areas, T, S and R. Figure 1A was obtained before, while Figure 1B was taken one month after brachytherapy treatment.

154489.png
Figure 1. Thermal imaging of one of analysed patient delineated areas. T area of the neoplastic lesion (T) and surrounding area S performed before (A) and 1 month (B) after treatment. Also marked reference (R) areas performed before (A) as well as 1 month after treatment (B)

All collected data is presented in Table 1. Initial analysis (data from Tables 1 and 2) yielded no statistically significant results.

Table 1. Temperature values derived from regions of interest for all studied group of patients

Temperature before treatment [°C ]

Temperature after treatment [°C ]

Difference in temperatures before treatment [°C ]

Difference in temperatures after treatment [°C ]

Target

Surrounding

Reference

Target

Surrounding

Reference

Target-Surrounding

Target-Reference

Surrounding Reference

Target-Surrounding

Target-Reference

Surrounding Reference

35,3

35

36,2

36,7

36,6

35,7

0,3

–0,9

–1,2

0,1

1

0.9

34

33,6

30,4

36,6

36,3

34,2

0,4

3,6

3,2

0,3

2,4

2.1

37,3

36,4

36,9

36,9

36,5

37

0,9

0,4

–0,5

0,4

–0,1

–0.5

34,5

34,3

35

36,8

36,4

36,8

0,2

–0,5

–0,7

0,4

0

–0.4

36,4

36,5

36,5

35,1

35,6

35,9

–0,1

–0,1

0

–0,5

–0,8

–0.3

34,2

33,7

34,8

32,1

31,7

33,2

0,5

–0,6

–1,1

0,4

–1,1

–1.5

34,1

34,2

34,3

36,7

36,5

36,3

–0,1

–0,2

–0,1

0,2

0,4

0.2

35,7

36

35,3

34,8

34,9

34,4

–0,3

0,4

0,7

–0,1

0,4

0.5

36,1

35,9

36,6

37

36,9

36

0,2

–0,5

–0,7

0,1

1

0.9

36,2

35,5

34,3

nd

nd

nd

0,7

1,9

1,2

0,2

0,2

0

34,9

35,4

35,3

35

35,3

34,9

–0,5

–0,4

0,1

–0,3

0,1

0.4

35,2

35

34,6

33,9

33,5

33,7

0,2

0,6

0,4

0,4

0,2

–0.2

35,7

35,1

35,5

36,6

36,4

35,2

0,6

0,2

–0,4

0,2

1,4

1.2

36,4

36,3

35,5

36,5

36,4

35,8

0,1

0,9

0,8

0,1

0,7

0.6

34,9

34,5

34,5

35,1

34,9

35

0,4

0,4

0

0,2

0,1

–0.1

35,6

35,4

34,3

36

36,1

34,7

0,2

1,3

1,1

–0,1

1,3

1.4

34,8

34,9

36

34,5

33,8

36

–0,1

–1,2

–1,1

0,7

–1,5

–2.2

34,7

32,9

33,9

32,9

30,9

34,5

1,8

0,8

–1

2

–1,6

–3.6

35,3

35

34,9

36,8

35,3

35,8

0,3

0,4

0,1

1,5

1

–0.5

34,2

34,3

34,2

36,4

35,7

36

–0,1

0

0,1

0,7

0,4

–0.3

33,4

34,9

32,9

36,8

35,9

36,3

–1,5

0,5

2

0,9

0,5

–0.4

35,9

36

35,8

32,4

32,3

35

–0,1

0,1

0,2

0,1

–2,6

–2.7

33,6

32,4

31,9

34,5

35,7

33,3

1,2

1,7

0,5

–1,2

1,2

2.4

35,5

35,1

35,1

37,2

36,8

36,6

0,4

0,4

0

0,4

0,6

0.2

33,8

34,1

34,3

31,7

30

33,1

–0,3

–0,5

–0,2

1,7

–1,4

–3.1

35

35,5

35,5

37,9

37,7

37,5

–0,5

–0,5

0

0,2

0,4

0.2

36,7

36,5

36,5

36

35,5

35,1

0,2

0,2

0

0,5

0,9

0.4

35,3

36

36,1

37,4

37,3

37,4

–0,7

–0,8

–0,1

0,1

0

–0.1

35,4

35,3

35,7

36

35,9

36,7

0,1

–0,3

–0,4

0,1

–0,7

–0.8

35,3

34,7

34

36

35,7

34,7

0,6

1,3

0,7

0,3

1,3

1

36,2

36,5

36,5

36

36,3

35,1

–0,3

–0,3

0

–0,3

0,9

1.2

34,5

35,5

35,8

36,8

37,4

35,7

–1

–1,3

–0,3

–0,6

1,1

1.7

35,1

35,3

35

35,9

36,2

35,8

–0,2

0,1

0,3

–0,3

0,1

0.4

Table 2. Analysis of obtained results from study group

Before treatment

After treatment

Target

Surrounding

Reference

Target

Surrounding

Reference

Average temperature

35.19

35.08

34.97

35.66

35.39

35.42

SD

0.93

1.01

1.37

1.60

1.86

1.17

SE

0.15

0.16

0.22

0.26

0.30

0.19

Temperature differences

Target Surrounding

Target Reference

Surrounding Reference

Target Surrounding

Target Reference

Surrounding Reference

Average Temperature

0.11

0.22

0.10

0.27

0.24

–0.03

SD

0.61

0.98

0.84

0.62

1.03

1.29

SE

0.10

0.16

0.14

0.10

0.17

0.22

In the next step, we classified patients into two subgroups according to obtained temperature gradient between lesion and its surroundings (dTTS).

The first group included 23 patients with positive dTTS recorded before HDR-BT (the temperature of the lesion was higher than its surroundings). One month after HDR-BT, the temperature of the lesion significantly decreased (p = 0.038) (Fig. 2). The other group of 14 patients had negative dT. In those patients, T area temperature raised significantly after HDR-BT (p = 0.008) (Fig. 3).

Kapek-2.png
Figure 2. The temperature changes calculated as dTTS = TTarget – Tsurroundings obtained in the group of patients with positive dT performed before and after brachytherapy (BT)
Kapek-3.png
Figure 3. The temperature changes calculated as dTTS = TTarget – Tsurroundings obtained in the group of patients with dT negative before and after brachytherapy (BT)

Discussion

The main goal of performed pre-studies was to try answer if there are any useful information that can be derived from temperature effects of HDR brachytherapy in the treatment of basal cell carcinoma. Moreover, a physical parameter taking into account the temperature of the lesion, its surrounding as well as reference area was introduced.

All studied patients suffering from BCC were examined using Infrared Thermography during the brachytherapy. The neoplastic lesion itself was drawn each time before and after BT.

Treatment effects monitoring is essential in cancer care as well as calculating possible side-effects (NTCP0). Patients with BCC who are non-surgical candidates may profit from a method that brings valuable data on the treatment efficacy at an early stage. Thermovision has features that may provide these. It is non-invasive, easy and reliable. The main issue is which data have an impact on different clinical decisions. Our initial analysis performed on the whole studied group (all studied patients as one group) did not find any significance in the temperature changes in the treated area. The significant changes in temperature parameters were only obtained when the specific and characteristic (as was shown) temperature gradient behavior between the tumour and surrounding tissues was considered. It should be noted that there are patients with positive dTTS with an average temperature difference of 0.3°C and those with negative dTTS of 0.6°C. In the case of the first group, HDR-BT leads to the decrease of the temperature gradient. On the other hand, the temperature behavior in the other group rises. It should be noted that observed temperature differences in both groups result in the alignment of studied areas temperature, which may suggest a healing process.

Trying to explain the origins of such different temperature responses, we should consider the effects of ionizing radiation and the clinical and morphological characteristics of the tumour itself. Ionizing radiation damages cells, causing radiolysis of water and the avalanche production of extremely reactive free radicals. Although direct death of a cell is possible through necrosis, apoptosis or autophagy, irradiation does not usually destroy the cell immediately. A damaged cell may appear morphologically unchanged. It may continue to function for some time or even perform cell division (i.e., mitotic death). Thus, the process of tumour disappearance after the application of HDR-BT may take place at a different time rate. There are different paths of cancer cell death and different biochemical mechanisms which vary among individuals.

Moreover, inflammatory reactions may occur in the case of tissue necrosis [25–27]. This reaction may lead to a specific temperature map of the body surface. Clinically, BCC has four main variants: superficial spreading, nodular, sclerosing and pigmented. BCC lesions may contain dilated vessels (telangiectasia) or melanin. Advanced tumors may ulcerate. Different structures and specificity of growth may also contribute to the occurrence of positive and negative temperature gradients in the analyzed group.

Even though our data are unique and pioneering, there is no clear answer to what dT may provide in everyday clinical practice, which requires further investigation. This method should be added to dermoscopy and included in the HDR-BT prospective trial to correlate its features with different variants of BCC and local control.

Conclusions

Thermal imaging may provide new quantitative information about thermal reactions of skin to ionizing radiation that were differentiated by temperature gradient between the lesion and its surrounding which may yield positive and negative values. The possibilities of temperature distribution in pre-irradiation cases might become one of parameters for estimation of clinical effects of standard treatment although this subject requires further research.

The results obtained from the study should be prospectively correlated with local control and dermoscopy and confirmed on bigger group of patients.

Institutional Review Board Statement

Approval of the Polish Bioethics Committee number 38/2016.

Conflict of interests

None declared.

Funding

None declared.

References

  1. Bakshi A, Chaudhary SC, Rana M, et al. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. Mol Carcinog. 2017; 56(12): 2543–2557, doi: 10.1002/mc.22690, indexed in Pubmed: 28574612.
  2. Wang H, Diepgen TL. The Epidemiology of Basal Cell and Squamous Cell Carcinoma. In: Reichrath J. ed. Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Medical Intelligence Unit. Springer, Boston 2006.
  3. Kopriva I, Persin A, Puizina-Ivić N, et al. Robust demarcation of basal cell carcinoma by dependent component analysis-based segmentation of multi-spectral fluorescence images. J Photochem Photobiol B. 2010; 100(1): 10–18, doi: 10.1016/j.jphotobiol.2010.03.013, indexed in Pubmed: 20409729.
  4. Ericson M, Sandberg C, Gudmundson F, et al. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B: Biology. 2003; 69(2): 121–127, doi: 10.1016/s1011-1344(02)00413-x.
  5. Lesiak A, Czuwara J, Kamińska-Winciorek G, et al. Basal cell carcinoma. Diagnostic and therapeutic recommendations of Polish Dermatological Society. Dermatol Rev. 2019; 106(2): 107–126, doi: 10.5114/dr.2019.85572.
  6. Hossfeld DK, Sherman CD, Love RR. Podręcznik onkologii klinicznej. PWN, Warszawa—Kraków 1994: 202–2046.
  7. Lo JS, Snow S, Reizner G, et al. Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991; 24(5): 715–719, doi: 10.1016/0190-9622(91)70108-e, indexed in Pubmed: 1869642.
  8. Cao D, Zhu Wu, Kuang Y, et al. A safe and effective treatment: Surgery combined with photodynamic therapy for multiple basal cell carcinomas. Photodiagnosis Photodyn Ther. 2019; 28: 133–135, doi: 10.1016/j.pdpdt.2019.09.001, indexed in Pubmed: 31521714.
  9. Feller L, Khammissa RAG, Kramer B, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face. Head Face Med. 2016; 12: 11, doi: 10.1186/s13005-016-0106-0, indexed in Pubmed: 26850723.
  10. Lanoue J, Goldenberg G. Basal Cell Carcinoma A Comprehensive Review of Existing and Emerging Nonsurgical Therapies; J Clin Aesthet Dermatol. J Clin Aesthet Dermatol. 2016; 9(5): 26–36, indexed in Pubmed: 27386043.
  11. Dika E, Scarfì F, Ferracin M, et al. Basal Cell Carcinoma: A Comprehensive Review. Int J Mol Sci. 2020; 21(15), doi: 10.3390/ijms21155572, indexed in Pubmed: 32759706.
  12. Guinot JL, Rembielak A, Perez-Calatayud J, et al. GEC ESTRO. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol. 2018; 126(3): 377–385, doi: 10.1016/j.radonc.2018.01.013, indexed in Pubmed: 29455924.
  13. Frometa-Castillo T, Pyakuryal A, Narayanasamy G, et al. The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments. Rep Pract Oncol Radiother. 2022; 27(4): 602–609, doi: 10.5603/RPOR.a2022.0063, indexed in Pubmed: 36196423.
  14. Jamora KE, Cereno RE, Inocencio ET, et al. Dermatofibrosarcoma protuberans of the upper eyelid treated with surface mould high-dose-rate brachytherapy. Rep Pract Oncol Radiother. 2022; 27(1): 182–187, doi: 10.5603/RPOR.a2021.0110, indexed in Pubmed: 35402039.
  15. Alam M, Nanda S, Mittal BB, et al. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011; 65(2): 377–388, doi: 10.1016/j.jaad.2010.03.027, indexed in Pubmed: 21496952.
  16. Hosseini M, Kasraian Z, Rezvani HR. Energy metabolism in skin cancers: A therapeutic perspective. Biochim Biophys Acta Bioenerg. 2017; 1858(8): 712–722, doi: 10.1016/j.bbabio.2017.01.013, indexed in Pubmed: 28161328.
  17. Kapek Ł, Cholewka A, Szurko A, et al. Monitoring PDT effects in basal cell carcinoma treatment using thermal imaging. Photodiagnosis Photodyn Ther. 2020; 31: 101845, doi: 10.1016/j.pdpdt.2020.101845, indexed in Pubmed: 32492520.
  18. Stringasci MD, Salvio AG, Moriyama LT, et al. Energy analysis of PDT using thermography during the treatment of basal cell carcinoma. Photodiagnosis Photodyn Ther. 2020; 29: 101586, doi: 10.1016/j.pdpdt.2019.101586, indexed in Pubmed: 31683031.
  19. Cholewka A, Stanek A, Kwiatek S, et al. Does the temperature gradient correlate with the photodynamic diagnosis parameter numerical colour value (NCV)? Photodiagnosis Photodyn Ther. 2013; 10(1): 33–38, doi: 10.1016/j.pdpdt.2012.07.001, indexed in Pubmed: 23465370.
  20. Baic A, Kasprzyk T, Rżany M, et al. Can we use thermal imaging to evaluate the effects of carpal tunnel syndrome surgical decompression? Medicine (Baltimore). 2017; 96(39): e7982, doi: 10.1097/MD.0000000000007982, indexed in Pubmed: 28953619.
  21. Cholewka A, Stanek A, Klimas A, et al. Thermal imaging application in chronic venous disease. J Thermal Anal Calorimetry. 2013; 115(2): 1609–1618, doi: 10.1007/s10973-013-3356-0.
  22. Cholewka A, Stanek A, Kwiatek S, et al. Application of thermovision to diagnosis of chosen skin cancer changes — preliminary studies. Pomiary Automatyka Kontrola. 2011; 10: 1142–1145.
  23. Ammer K. The Glamorgan Protocol for recording and evaluation of thermal images of the human body. Thermology Int. 2008; 18(4): 125–129.
  24. Flores-Sahagun JH, Vargas J, Mulinari-Brenner FA. Analysis and diagnosis of basal cell carcinoma (BCC) via infrared imaging. Infrared Phys Technol. 2011; 54(5): 367–378, doi: 10.1016/j.infrared.2011.05.002.
  25. Frączak M. Podstawy diagnostyki i terapii nowotworów. 1 ed. Alfa-Medica Press, Bielsko-Biała 2008.
  26. Hrynkiewicz A. Człowiek i promieniowanie jonizujące. 1st ed. PWN, Warszawa 2001.
  27. Kumar V, Cotran RS, Robbins S. Basic Pathology. 7th ed. Wydawnictwo Medyczne Urban & Partner, Wrocław 2011.